A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2004
12/16/2004	US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
12/16/2004	US20040254128 Treatment and prevention of heat shock protein-associated diseases and conditions
12/16/2004	US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation
12/16/2004	US20040254107 Biphasic mixtures of glp-1 and insulin
12/16/2004	US20040254093 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antidiabetic agents
12/16/2004	US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
12/16/2004	US20040253685 eNOS mutations useful for gene therapy and therapeutic screening
12/16/2004	US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders
12/16/2004	US20040253597 Sodium dependent dicarboxylate transport protein for use in identifying modulators for prevention/treatment of hepatic, prostate, splenic, renal diseases, metabolic, circulatory, cancer and aging disorders
12/16/2004	US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004	US20040253329 Ligand for peroxisome proliferator-activated receptor
12/16/2004	US20040253322 Mixtures of clinoptilolite, plant extracts and vitamins, used for attenuation of neuropathic pain associated with diabetes or prevent deposition of immunoglobulin on axons
12/16/2004	US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
12/16/2004	US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application
12/16/2004	US20040253274 Use of a clostridial toxin to reduce appetite
12/16/2004	US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004	US20040253205 c-Kit kinase inhibitor
12/16/2004	CA2528164A1 Solid preparation
12/16/2004	CA2527934A1 Tetrazol benzofurancarboxamides with p13k activity as therapeutic agents
12/16/2004	CA2527779A1 3-substituted indoles and derivatives thereof as therapeutic agents
12/15/2004	EP1486497A1 Novel pyridone derivative
12/15/2004	EP1486490A1 Azole compounds
12/15/2004	EP1486488A1 Use of a compound of formula I for making a pharmaceutical composition
12/15/2004	EP1485482A1 Inhibition of the beta3 subunit of l-type ca 2+ channels
12/15/2004	EP1485405A2 Melanin-concentrating hormone analogs
12/15/2004	EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same
12/15/2004	EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485380A1 Azolylaminoazines as inhibitors of protein kinases
12/15/2004	EP1485379A1 Beta 3-adrenergic receptor agonists
12/15/2004	EP1485371A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485347A2 Hif hydroxylase inhibitors
12/15/2004	EP1485343A1 Amorphous hmg-coa reductase inhibitors of desired particle size
12/15/2004	EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
12/15/2004	EP1485105A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
12/15/2004	EP1485104A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
12/15/2004	EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
12/15/2004	EP1485092A1 Use of rapamycin for inhibiting of cell death
12/15/2004	EP1485091A1 Thiazole and oxazole derivatives that modulate ppar activity
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
12/15/2004	EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/15/2004	EP1453954A4 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
12/15/2004	EP1414470A4 Micronutrient phosphates as dietary and health supplements
12/15/2004	EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals
12/15/2004	EP1399155A4 Small molecules useful in the treatment of inflammatory disease
12/15/2004	EP1373216B1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
12/15/2004	EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients
12/15/2004	EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof
12/15/2004	EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/15/2004	EP1226160B1 Novel antiarrhythmic peptides
12/15/2004	EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004	EP1149063B1 Ureido-thiobutyric acid derivatives as ppar-agonists
12/15/2004	EP1119543B1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
12/15/2004	EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors
12/15/2004	CN1555367A 3-substituted-4-pyrimidone derivatives
12/15/2004	CN1555361A Butyric acid derivatives
12/15/2004	CN1555356A Bisphenol derivative as NHE-3 inhibitor
12/15/2004	CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004	CN1555351A Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1555266A Hormone replacement therapy
12/15/2004	CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity
12/15/2004	CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals
12/15/2004	CN1555227A Enteral formulations
12/15/2004	CN1554651A Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
12/15/2004	CN1554626A Eudesmane compounds, preparing method and use in preparing medicinal composition
12/15/2004	CN1554422A Chinese-western composite medicine for treating diabetes and its preparing method
12/15/2004	CN1554410A Worm nutritiou health oral liquid and its preparing method
12/15/2004	CN1554408A Medicine for lowering blood lipid and softening blood vessel and its preparing method
12/15/2004	CN1554400A Use of seniawinii in preparing anti-depression, improving brain or/and defatting medicine or food
12/15/2004	CN1554376A Nutrition metabolic acid-base balance regulating agent and its producing process
12/15/2004	CN1554371A Blood lipid capsule and its preparing method
12/15/2004	CN1554361A Nano calcium
12/15/2004	CN1554349A Dry mix formulation for bisphosphonic acids
12/15/2004	CN1554333A Use of dextro sibutramine and its corresponding salt in preparing fat-reducing medicine
12/15/2004	CN1554328A Microball preparation for intestine orient releasing medicne and its preparing method
12/15/2004	CN1554285A Method for producing oyster tablet by adding oyster shell superfine powder
12/15/2004	CN1554253A Shayintongxin tea
12/15/2004	CN1179970C Purine derivatives
12/15/2004	CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications
12/15/2004	CN1179952C Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
12/15/2004	CN1179740C Method for extracting and separating effective part from dogbane
12/15/2004	CN1179734C Chinese medicine capsule for treating diabetes
12/14/2004	US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004	US6831162 Protein/polypeptide-k obtained from Momordica charantia and a process for the extraction thereof
12/14/2004	US6831106 Vitamin D analogues
12/14/2004	US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/14/2004	US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
12/14/2004	US6831093 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
12/14/2004	US6831091 Anticancer agents
12/14/2004	US6831082 Method of using soluble epoxide hydrolase inhibitors
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/14/2004	US6831070 Delivery of therapeutic gene products by intestinal cell expression
12/14/2004	US6831069 Pyrrolo[2,3-d]pyrimidine nucleoside analogs

1 ... 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 ... 1298